A Registry Study of Patients Hospitalized With Confirmed COVID-19

A Registry Study of Patients Hospitalized With Confirmed COVID-19

The design of this registered study aims to evaluate the efficacy and safety of Paxlovid in the treatment of hospitalized COVID-19 patients, and to explore factors related to the efficacy and safety of Paxlovid.

Inclusion Criteria:

1. Confirmed diagnosis of COVID-19 infection.
2. Presence of at least one high-risk factor, including age ≥60 years, diabetes, hypertension, cardiovascular disease, stroke, chronic liver or kidney disease, cancer, history of smoking or obesity.

Exclusion Criteria:

• No specific exclusion criteria in this study.